Search for: "SHIRE US INC."
Results 61 - 80
of 103
Sort by Relevance
|
Sort by Date
4 Aug 2010, 12:21 am
Roxane Laboratories Inc. [read post]
14 Jul 2010, 6:47 pm
(Patent Docs) Lialda (Mesalazine /Mesalamine) – US: Patent infringement complaint following Paragraph IV certification: Shire Development Inc. et al. v. [read post]
10 Jun 2010, 3:58 am
(SmartBrief) Emend (Aprepitant) - US: Sandoz counterclaims for two patents dismissed in Merck’s Emend suit (Patent Docs) Intuniv (Guanfacine) – US: Patent infringement complaint based on ANDA filing: Shire LLC et al. v. [read post]
6 Jun 2010, 8:45 pm
Anchen Pharmaceuticals Inc. et al. 1:10-cv-00484; filed June 2, 2010 in the District Court of Delaware • Plaintiffs: Shire LLC; Supernus Pharmaceuticals Inc.; Amy F.T. [read post]
3 Jun 2010, 1:37 pm
Shire US, Inc., 415 F. [read post]
27 May 2010, 3:20 am
Nycomed US Inc. et al. [read post]
5 May 2010, 4:46 am
(Patent Docs) Intuniv (Guanfacine) – US: Shire files patent suit against Teva over its plans to market generic Intuniv (Patent Quality Review Blog) (Patent Docs) Istodax (Romidepsin) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. v. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix… [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint… [read post]
29 Mar 2010, 5:00 am
Shire, Inc., 2010 WL 937279 (Pa. [read post]
2 Feb 2010, 11:25 am
Because they're so useful! [read post]
2 Feb 2010, 11:25 am
Because they're so useful! [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) Carbatrol (Carbamazepine) – US: Settlement announced in patent dispute between Shire and Apotex over Carbatrol (Patent Docs) Combigan (Brimonidine tartrate/Timolol maleate): US: Patent infringement suit following a Paragraph IV certification Allergan, Inc. v. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) Carbatrol (Carbamazepine) - US: Settlement announced in patent dispute between Shire and Apotex over Carbatrol (Patent Docs) Combigan (Brimonidine tartrate/Timolol maleate): US: Patent infringement suit following a Paragraph IV certification Allergan, Inc. v. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA, Inc. et al (Patent Docs) Carbatrol (Carbamazepine) - US: Settlement announced in patent dispute between Shire and Apotex over Carbatrol (Patent Docs) Combigan (Brimonidine tartrate/Timolol maleate): US: Patent infringement suit following a Paragraph IV certification Allergan, Inc. v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) –… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US:… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US:… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’… [read post]
